Academic Journal
Q1Drug Metabolism and Disposition
About Drug Metabolism and Disposition
About Drug Metabolism and Disposition
Drug Metabolism and Disposition is a peer-reviewed scholarly journal published by Elsevier B.V. (United States). It focuses on Q1. Publication coverage spans 1973-2026.
Key indicators: ISSN 0090-9556, 1521-009X; H-index 202.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (202): Exceptionally high — 202 articles have each been cited at least 202 times. This indicates deep, sustained influence in the field.
Publishing in Drug Metabolism and Disposition
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Drug Metabolism and Disposition?
0090-9556, 1521-009X.
Who publishes Drug Metabolism and Disposition?
Elsevier B.V..
What are Drug Metabolism and Disposition's metrics?
H-index 202.
Is Drug Metabolism and Disposition peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Pharmacogenetics and Drug Metabolism; Drug Transport and Resistance Mechanisms; Pharmacological Effects and Toxicity Studies; Drug-Induced Hepatotoxicity and Protection; Eicosanoids and Hypertension Pharmacology; Metabolism and Genetic Disorders.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
3,500.00 USD; 3,270.00 EUR; 2,800.00 GBP; 434,110.00 JPY
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Functional characterization of rare DPYD variants identified in 8,380 Japanese individuals: implications for 5-fluorouracil metabolism
Kento Terauchi, Eiji Hishinuma, Akiko Ueda, Shota Nishihara et al.
2026-11 · DOI: 10.1016/j.dmd.2026.100408Impact of nonspecific binding to membrane vesicles on unbound IC50 estimation for P-glycoprotein and breast cancer resistance protein inhibitors and implications for drug-drug interaction risk assessment
Renjie Zhan, Richard Moulton, Scott Tallman, Shelby Hullett et al.
2026-11 · DOI: 10.1016/j.dmd.2026.100411Repaglinide metabolism by human hepatocytes reveals CYP2C8 dominance and misassignment of CYP3A4 by liver subcellular fractions and recombinant enzymes
Tashinga E. Bapiro
2026-10 · DOI: 10.1016/j.dmd.2026.100400Liposomal encapsulation redirects the in vivo disposition of paclitaxel: a comparative pharmacokinetic, tissue distribution, and excretion study in rats
Guolei Zhang, Ning Zhang, Yu Miao, Yidan Zhang et al.
2026-10 · DOI: 10.1016/j.dmd.2026.100406When microbial drug metabolism becomes a drug disposition variable
Rebecca Lewandowski
2026-10 · DOI: 10.1016/j.dmd.2026.100407Proteomic characterization of human kinases across tissue types: Implications for kinase-activated drugs
Griffin D. Shaffer, Dilip Kumar Singh, Sandhya Subash, Bhagwat Prasad et al.
2026-10 · DOI: 10.1016/j.dmd.2026.100385Systemic inflammation reprograms human hepatic phenotype and suppresses absorption, distribution, metabolism, and excretion gene expression: Validation in a 3-dimensional human liver spheroid system
Inger Johansson, Allan Zhao, Lili Milani, Qiaolin Deng et al.
2026-10 · DOI: 10.1016/j.dmd.2026.100384The absorption, distribution, metabolism, excretion, and pharmacokinetic properties of the pan–rapidly accelerated fibrosarcoma (RAF) inhibitor naporafenib in healthy subjects: An absolute bioavailability and mass balance study
Justine L. Lam, Zhongzhou Shen, Alfin Vaz, Roxana Picard et al.
2026-10 · DOI: 10.1016/j.dmd.2026.100389Systematic evaluation of five classical mechanistic methods for tissue-plasma partition coefficients across diverse tissues and compound classes
Jia Geng, Ammara Ayub, Feifan Xie
2026-10 · DOI: 10.1016/j.dmd.2026.100405Proteomic profiling of drug and nutrient transporter expression by small intestinal region in neonates, pediatrics, and adults
Vicky L. Sun, Kai Wang, Joanne Wang, Jashvant D. Unadkat et al.
2026-10 · DOI: 10.1016/j.dmd.2026.100398Evaluation of a Long-Term Human Hepatocyte Culture Maintained in PowerHEP Maintenance Medium for Drug Clearance Prediction
Qianying Yuan, Mitchell Laughlin, Xiaofeng Wu, Sam Zhang et al.
2026-10 · DOI: 10.1016/j.dmd.2026.100419The Relationship Between Age and Endogenous Biomarkers of Organic Anion Transporters 1 and 3 (OAT1/3) in Preterm Neonates: A Cross-sectional Study
Mohamed Y. Abdelgaied, Cheri Gauldin, William Truog, Tamorah Lewis et al.
2026-10 · DOI: 10.1016/j.dmd.2026.100420A novel in vitro permeability and efflux classification system for proteolysis targeting chimeras
Siennah R. Greenfield, Philip Sandoval, Sara P. Puckett, Erika Kojima et al.
2026-10 · DOI: 10.1016/j.dmd.2026.100369A herb–drug interaction: The role of transporters in the modulation of atorvastatin absorption by Compound Danshen Tablets
Ke Zhang, Fofo Jiang, Ziting Li, Feng Zhao et al.
2026-10 · DOI: 10.1016/j.dmd.2026.100380Liquid chromatography–high-resolution mass spectrometry–based integrated strategy combining in silico prediction and molecular networking for metabolite identification of podophyllotoxin in a fatal poisoning case
Mengyi Wu, Jialin Feng, Junbo Zhao, Huosheng Qiang et al.
2026-10 · DOI: 10.1016/j.dmd.2026.100393In Vitro-In Vivo Extrapolation of Hepatic Clearance for GalNAc-siRNA Therapeutics Using Rat Liver Tritosomes
Harvey Andersen, Alec Bell, Ryan Hill, Anthony Murphy et al.
2026-10 · DOI: 10.1016/j.dmd.2026.100415Absorption, distribution, metabolism, excretion, and pharmacokinetics of remibrutinib, an oral, highly selective, Bruton’s tyrosine kinase inhibitor, in healthy participants at steady state
Alexander David James, Frederic Lozac’h, Melissa Hackling, Marie-Anne Lozac’h et al.
2026-10 · DOI: 10.1016/j.dmd.2026.100417From systemic circulation to male gametes: Comparative pharmacokinetics of ivermectin in plasma, seminal plasma, and spermatozoa of Awassi rams
Zeynep Ozdemir Kutahya, Erkan Say, Ebru Karakaya Bilen, Busra Aslan Akyol et al.
2026-10 · DOI: 10.1016/j.dmd.2026.100396Integrated assessment of cytochrome P450 inhibition by açaí and mass spectrometry–based identification of P450 inhibitory constituents using biochemometric approaches
Zarna Raichura, Michael Zirpoli, Rebecca Paul-Hamby, Chris Harrilal et al.
2026-10 · DOI: 10.1016/j.dmd.2026.100388Impact of alcohol consumption on CYP1A2 activity in human liver microsomes studied with a new naphthalene-based fluorogenic substrate
Kari A. Gaither, Nadezhda Y. Davydova, Kannapiran Ponraj, Dilip Kumar Singh et al.
2026-10 · DOI: 10.1016/j.dmd.2026.100392Reviews
Community Reviews
Version History
October 9, 2026 at 8:33 pm
September 25, 2026